1-3 of 3
Hans Theodor Eich, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discrimination of an Early Unfavorable Risk Group Has Significant Impact On Treatment Outcome in Early-Stage Hodgkin Lymphoma: An Analysis of International Staging Definitions and Risk Factors

Free
Beate Klimm, MD, Helen Goergen, Michael Fuchs, MD, Bastian von Tresckow, MD, Volker Diehl, MD, Hans Theodor Eich, MD, Andreas Engert, MD, Peter Borchmann, MD
Journal: Blood
Blood (2012) 120 (21): 54.
https://doi.org/10.1182/blood.V120.21.54.54
Published: 2012
Journal Articles

Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

Free
Annette E. Hay, MBChB, Beate Klimm, MD, Bingshu E. Chen, PhD, Helen Goergen, Lois E. Shepherd, M.D., Michael Fuchs, MD, Mary Gospodarowicz, MD, Peter Borchmann, MD, Joseph M. Connors, MD, Jana Markova, MD, Michael Crump, MD, FRCPC, Andreas Lohri, MD, Jane N. Winter, MD, Bernd Dörken, Robert G. Pearcey, MD, Volker Diehl, MD, Sandra J. Horning, M.D., Hans Theodor Eich, MD, Andreas Engert, MD, Ralph M. Meyer, MD
Journal: Blood
Blood (2012) 120 (21): 548.
https://doi.org/10.1182/blood.V120.21.548.548
Published: 2012
Journal Articles

Reduced Intensity of Chemotherapy and PET-Guided Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma: The GHSG HD15 Final Results

Free
Andreas Engert, MD, Heinz Haverkamp, Carsten Kobe, MD, Jana Markova, MD, Christoph Renner, MD, Anthony D. Ho, MD, PhD, Josée Zijlstra, MD, Zdenek Král, MD, Harald Stein, MD, Hans Theodor Eich, MD, Rolf-Peter Müller, MD, Markus Dietlein, MD, Peter Borchmann, MD, Volker Diehl, MD
Journal: Blood
Blood (2011) 118 (21): 589.
https://doi.org/10.1182/blood.V118.21.589.589
Published: 2011